However, the biosensor results also demonstrate the possibility of a robust, specific analysis of additional markers such as glial fibrillary acidic protein [29], suggesting the potential of a multiplex stroke panel for even greater diagnostic accuracy. This evidence concerns the gene GFAP and stroke disorder.